Optional Friday Courses / ACG’s 2015 Three-Day Clinical Review
GI Pathophysiology Course
Friday, October 16, 2015 • 6:30 am – 11:30 am • 310 Theater
Course Director: Michael F. Vaezi, MD, PhD, MSc(Epi), FACG
ACG Members/Fellows: ACG Resident/Trainee/Candidate Members: ACG PA / NP/Allied Health Members:
All Non-Members: 6:30 am Welcome and Introduction
Michael F. Vaezi, MD, PhD, MSc(Epi), FACG
$200
$160
$175
$225
6:35 am Eosinophilic Esophagitis: Pathophysiology
Directing Treatment
Ikuo Hirano, MD, FACG
Outline the etiology for eosinophilic esophagitis and
discuss state of the art literature on diagnosis and
treatment of this condition.
Course Description
Gain a better understanding of gastrointestinal course available on
disease processes and their impact on
clinical presentation of patients when you
attend ACG’s GI Pathophysiology Course.
Experts will review the underlying causes and
clinical implication of commonly encountered
diseases seen in practice. The outline
includes discussion of pathophysiology of
eosinophilic esophagitis, gastric and intestinal
motility, H. pylori, gut microbiota, IBD, celiac disease, and endocrine
neoplasms of the pancreas. Lecture presentations will be followed
by interactive question and answer sessions. The discussions will be
clinically based and will offer points on how to better help patients
with difficult-to-manage disease processes. The course faculty are
recognized experts in their fields and pioneers in better understanding
of the disease processes in gastroenterology. The course is designed
primarily for clinicians in GI/hepatology, as well as physician assistants,
nurse practitioners, and other advanced practice healthcare
professionals interested in the clinical application of GI pathophysiology.
7:15 am
Gastric and Intestinal Motility: From Normal to
Dysfunction
Satish S. C. Rao, MD, PhD, FACG
Review the physiology of gastric and intestinal motility
and outline clinical conditions in which motility
dysfunction leads to disease.
7:55 am
Helicobacter pylori Involvement in Peptic Ulcer
Disease, Gastric Cancer, Dyspepsia and Reflux: What the Clinician Should Know
Douglas R. Morgan, MD, MPH, FACG
Discuss the role of commonly encountered H. pylori in
gastric pathology including peptic ulcer disease, cancer
and dyspepsia and review its role in GERD.
8:35 am Dysbiosis, Obesity and NAFLD: What Every
Gastroenterologist Needs to Know
Zobair M. Younossi, MD, MPH, FACG
Gut microbiota are involved in sustaining health and
their imbalance may result in various GI disorders.
Better understanding is needed for the role of enteric
microbiota in obesity and liver disease such as NAFLD.
Accreditation
9:15 am Break
The American College of Gastroenterology is accredited by the
Accreditation Council for Continuing Medical Education (ACCME)
to provide continuing medical education for physicians.
9:30 am Mucosal Healing in the Era of Biologic Agents for
Treating IBD
David T. Rubin, MD, FACG
Discuss recent developments in IBD including the role
of mucosal healing in the era of biologic agents.
The American College of Gastroenterology designates this live
activity for a maximum of 4.75 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the
extent of their participation in the activity.
10:10 am Celiac Disease: From Etiology to Therapy
Joseph A. Murray, MD, FACG
Assess the mechanisms and discuss the exciting
new diagnostic options and treatment strategies for
patients with celiac disease.
Faculty
Course Director – Michael F. Vaezi, MD, PhD, MSc(Epi), FACG
Jamie S. Barkin, MD, MACG
Ikuo Hirano, MD, FACG
Douglas R. Morgan, MD, MPH, FACG
Joseph A. Murray, MD, FACG
Satish S. C. Rao, MD, PhD, FACG
David T. Rubin, MD, FACG
Zobair M. Younossi, MD, MPH, FACG
10:50 am Endocrine Neoplasms of the Pancreas: When to Suspect? How to Diagnose?
Jamie S. Barkin, MD, MACG
Formulate up to date information on endocrine
neoplasms of the pancreas with emphasis on patient
presentation and optimal diagnostic testing strategies.
11:30 am Course Adjourns
42
Optional Friday Courses / ACG’s 2015 Three-Day Clinical Review
GI Pathophysiology Course
Friday, October 16, 2015 • 6:30 am – 11:30 am • 310 Theater
Course Director: Michael F. Vaezi, MD, PhD, MSc(Epi), FACG
Faculty Listing and Disclosure Information
The American College of Gastroenterology (ACG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to
provide continuing medical education for physicians. ACG, as an ACCME accredited provider, ensures balance, independence, objectivity, and
scientific rigor in all of its directly and jointly provided education activities. All who are in a position to control the content of an education activity (including their spouse or partner) are required to disclose to ACG all relevant financial relationships in any amount occurring in the past
12 months with any commercial interest that may create a conflict of interest related to the subject matter of an education activity. Safeguards
against commercial bias have been put in place by ACG. Anyone who refuses to disclose relevant financial relationships will be disqualified.
ACG ensures any conflicts of interest are resolved before the educational activity occurs and discloses all relevant financial relationships to the
learners prior to the beginning of an education activity.
ACG staff involved with this activity have nothing to disclose. Faculty have noted the following relationships related to their GI Pathophysiology
Course presentations.
Zobair M. Younossi, MD, MPH, FACG
Chairman, Department of Medicine; VP for Research, Inova
Health System, Falls Church, VA
Dr. Younossi has indicated no relevant financial relationships.
Course Director
Michael F. Vaezi, MD, PhD, MSc(Epi), FACG
Professor of Medicine, Vanderbilt University Medical Center,
Nashville, TN
Research Grant: Sandhill Scientific
Investigational Use Disclosures
ACG’s disclosure policy maintains that if any unapproved or
off-label use of a product is to be referenced in a CME program,
the faculty member is required to disclose that the product
is either investigational or it is not labeled for the usage being
discussed. The following faculty member(s) have indicated they
may reference an off-label use in their GI Pathophysiology Course
presentation(s).
Faculty
Jamie S. Barkin, MD, MACG
Professor of Medicine, University of Miami, Miller School of
Medicine, Miami, FL
Dr. Barkin has indicated no relevant financial relationships.
Ikuo Hirano, MD, FACG
Professor of Medicine, Northwestern University Feinberg School of
Medicine, Chicago, IL
Consultant: Meritage Pharmaceuticals, Receptos, Regeneron
Douglas R. Morgan, MD, MPH, FACG
Associate Professor of Medicine, Division of Gastroenterology,
Hepatology and Nutrition, Vanderbilt University, Nashville, TN
Dr. Morgan has indicated no relevant financial relationships.
Joseph A. Murray, MD, FACG
Professor of Medicine, Consultant, Division of Gastroenterology and
Hepatology and Department of Immunology, Mayo Clinic, Rochester,
MN
Advisory Committee/Board Member: Alvine Pharmaceuticals, Inc.
Consultant: AMAG Pharmaceuticals, BioLineRx, Entera Health,
Inc., Genentech, GlaxoSmithKline, Glenmark Pharmaceuticals,
Sonomaceuticals
Grant/Research Support: Alba Therapeutics, Alvine Pharmaceuticals,
Inc.
Patent Holder: Miomics
Satish S. C. Rao, MD, PhD, FACG
Professor of Medicine, Georgia Regents University, Augusta, GA
Advisory Committee/Board Member: American Medical Systems,
Forest Laboratories, Hollister, In Control Medical, Ironwood
Pharmaceuticals
Grant/Research Support: Covidien, Salix Pharmaceuticals, Sun Sweet
Corporation, Synergy Pharmaceuticals, Ventrus Laboratories
David T. Rubin, MD, FACG
Professor of Medicine, University of Chicago Medicine, Chicago, IL
Consultant: Abbott/AbbVie, Amgen, EMMI, Genentech, Janssen,
Pfizer, Prometheus, Santarus, Shire, Takeda, Telsar Pharmaceuticals,
UCB
Grant/Research Support: Abbott/AbbVie, Genentech, Janssen,
Prometheus, Shire, Takeda, UCB
Co-Founder (non-profit medical education company): Cornerstones
Health Inc.
Dr. Hirano – No medications or diet therapies are FDA
approved for eosinophilic esophagitis at this time. All
therapies are being used off label.
43
EDUCATIONAL
PROGRAMS
Peer Review Subcommittee Members
To resolve identified conflicts of interest, the educational content
was peer reviewed by the Course Director or a member of the ACG
Educational Affairs Peer Review Subcommittee.
J. David Horwhat, MD, FACG,
Mark T. DeMeo, MD, FACG, Lancaster, PA
Chair, Burr Ridge, IL
Dr. Horwhat has indicated no
Dr. DeMeo has indicated no
relevant financial relationships.
relevant financial relationships.
Joseph C. Anderson, MD, FACG, Amy S. Oxentenko, MD, FACG,
Rochester, MN
Hanover, NH
Dr. Oxentenko has indicated no
Dr. Anderson has indicated no
relevant financial relationships.
relevant financial relationships.
Michael A. Poles, MD, Steven L. Carpenter, MD,
New York, NY
Savannah, GA
Dr. Poles has indicated no relevant
Dr. Carpenter has indicated no
financial relationships.
relevant financial relationships.
Francisco C. Ramirez, MD, FACG,
Joseph G. Cheatham, MD, Scottsdale, AZ
San Diego, CA
Dr. Ramirez has indicated no
Dr. Cheatham has indicated no
relevant financial relationships.
relevant financial relationships.
Aasma Shaukat, MD, MPH, FACG,
Edith Y. Ho, MD, Cleveland, OH
Minneapolis, MN
Dr. Ho has indicated no relevant
Dr. Shaukat has indicated no
financial relationships.
relevant financial relationships.